Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling

Lung cancer is the most deadly neoplasm with the highest incidence in both genders, with non-small cell lung cancer (NSCLC) being the most frequent subtype. Somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene are key drivers of NSCLC progression, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Raquel-Cunha, Ana, Cardoso-Carneiro, Diana, Reis, Rui M., Martinho, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562953/
https://www.ncbi.nlm.nih.gov/pubmed/31083461
http://dx.doi.org/10.3390/cells8050442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562953/
https://www.ncbi.nlm.nih.gov/pubmed/31083461
http://dx.doi.org/10.3390/cells8050442

Ejemplares similares